Significant Ownership of FEDERATED HERMES, INC.

Signature - Title
/s/J. Christopher Donahue - J. Christopher Donahue, as President of Federated Hermes, Inc.
Location
Pittsburgh, PA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by FEDERATED HERMES, INC..

Notify me when FEDERATED HERMES, INC. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of FEDERATED HERMES, INC.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NERV Minerva Neurosciences, Inc. Common Stock 19.32% $3.32M 1.35M Federated Hermes, Inc. 21 Oct 2025
FBRX Forte Biosciences, Inc. COMMON STOCK 13.15% $18.7M $1.79M 1.64M +10.6% Federated Hermes, Inc. 30 Sep 2025
SCYX SCYNEXIS INC COMMON STOCK 11.26% $6.04M -$1.55M 5.12M -20.4% Federated Hermes, Inc. 30 Sep 2025
ATYR aTYR PHARMA INC COMMON STOCK 10.76% $55.5M -$21.7M 10.5M -28.1% Federated Hermes, Inc. 30 Sep 2025
SSTI SOUNDTHINKING, INC. COMMON STOCK 7.82% $12.1M 1M Federated Hermes, Inc. 30 Sep 2025
EYPT EYEPOINT PHARMACEUTICALS, INC. COMMON STOCK 6.68% $43.3M 4.6M Federated Hermes, Inc. 30 Jun 2025
MGPI MGP INGREDIENTS INC COMMON STOCK 5.17% $26.7M 1.1M Federated Hermes, Inc. 31 Oct 2025
SPCE VIRGIN GALACTIC HOLDINGS, INC. COMMON STOCK 0.51% $651K -$5.41M 210K -89.3% Federated Hermes, Inc. 31 May 2025

Schedules 13D/G Reported by FEDERATED HERMES, INC.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.